In early stages of chronic liver disease and onset of HCC development, TGF-β is described to fulfil tumor suppressive and cytostatic functions, well represented by induction of apoptosis and proliferation inhibition by TGF-β in PLC, HepG2, Hep3B and HuH7. This evidence concerns the gene HSPG2 and neoplasm.